Advances in Precision Medicine Approaches for Type 2 Diabetes Management: A Comprehensive Review

References (49)

1. 1 Diagnosis and Classification of Diabetes Mellitus [DOI]
2. 2 Global aetiology and epidemiology of type 2 diabetes mellitus and its complications [DOI]
3. 3 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 [DOI]
4. 4 WHO Global report on diabetes: A summary [DOI]
5. 5 Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [DOI]
6. 6 Precision medicine in 2030—seven ways to transform healthcare [DOI]
7. 7 Association of History of Gestational Diabetes With Long-term Cardiovascular Disease Risk in a Large Prospective Cohort of US Women [DOI]
8. 8 The Cells of the Islets of Langerhans [DOI]
9. 9 Painting a new picture of personalised medicine for diabetes [DOI]
10. 10 Artificial intelligence for precision medicine in neurodevelopmental disorders [DOI]
11. 11 ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents [DOI]
12. 12 The Cost of Diabetes Care—An Elephant in the Room [DOI]
13. 13 Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go [DOI]
14. 14 Phenotypic and genetic classification of diabetes [DOI]
15. 15 Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine [DOI]
16. 16 Precision medicine in type 2 diabetes [DOI]
17. 17 Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program [DOI]
18. 18 Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications [DOI]
19. 19 Minimal clinically important difference for impulse oscillometry in adults with asthma [DOI]
20. 20 Personalized medicine in diabetes mellitus: current opportunities and future prospects [DOI]
21. 21 Psychosocial barriers to healthcare use among individuals with diabetes mellitus: A systematic review [DOI]
22. 22 The P4 Health Spectrum – A Predictive, Preventive, Personalized and Participatory Continuum for Promoting Healthspan [DOI]
23. 23 Genetic Loci and Physiologic Pathways Involved in Gestational Diabetes Mellitus Implicated Through Clustering [DOI]
24. 24 Genome access and other web-based IT solutions: Genetic counseling in the digital era [DOI]
25. 25 Diabetes conflict outstrips the positive impact of self-efficacy on youth adherence and glycemic control in type 1 diabetes [DOI]
26. 26 Telomeres in clinical diabetes research – Moving towards precision medicine in diabetes care? [DOI]
27. 27 Precision medicine‐based drug treatment individualization in oncology [DOI]
28. 28 Type 2 Diabetes [DOI]
29. 29 One size does not fit all: an historian’s perspective on precision diabetes medicine [DOI]
30. 30 Implementation of Precision Genetic Approaches for Type 1 and 2 Diabetes [DOI]
31. 31 Lifestyle intervention and impaired glucose tolerance in the Da Qing study [DOI]
32. 32 Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy [DOI]
33. 33 Serotonin receptor 3B polymorphisms are associated with type 2 diabetes: The Korean Genome and Epidemiology Study [DOI]
34. 34 From basic research to personalized medicine [DOI]
35. 35 Relevance of Precision Medicine in Public Health Genomics and Global Health Genomics [DOI]
36. 36 Towards an effective medicine of precision by using conceptual modelling of the genome [DOI]
37. 37 Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87) [DOI]
38. 38 Environmental and Genetic Factors Contributing to Bladder Carcinogenesis [DOI]
39. 39 The WHO diabetes targets and their potential to improve the lives of people with diabetes [DOI]
40. 40 Latent Autoimmune Diabetes in Adults (LADA): The Prevalent Form of Adult-Onset Autoimmune Diabetes in a Region of India [DOI]
41. 41 Thinking broader in diabetes care [DOI]
42. 42 Management of Type 2 Diabetes Mellitus: A Pathophysiologic Approach [DOI]
43. 43 Precision Medicine: FDA Oncology Perspective [DOI]
44. 44 Precision Medicine, Imprecise Health Care Justice [DOI]
45. 45 Getting it right first time – precision medicine in diabetes [DOI]
46. 46 Precision dosing in clinical medicine: present and future [DOI]
47. 47 The Need for Precision Medicine to be Applied to Diabetes [DOI]
48. 48 Early Detection of Type 2 Diabetes Mellitus Using Deep Neural Network–Based Model [DOI]
49. 49 Faculty Opinions recommendation of Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. [DOI]

Cited by 0

No indexed citations yet.

Related research

• First Trimester Fasting Blood Glucose as a Screening Tool for Diabetes Mellitus in a Teaching Hospital Setting in Nigeria — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• Effect of Aqueous Extract of Persea americana Seed on Blood Glucose in Alloxan-induced Diabetic Wistar Rats — shares topic coverage
• Metal Based α-glucosidase Inhibitors: Synthesis, Characterization and α-glucosidase Inhibition Activity of Transition Metal Complexes — shares topic coverage
• Evaluation of Fluid Therapy by Point-of-Care Ultrasound in Hyperglycemic Emergencies — shares topic coverage